Where Science Connects

Synapse Communications Consulting works with biotech companies, investors, and community organizations to translate complex science into regulatory submissions, investor narratives, and ecosystem strategies that move things forward.

An editorial style image of a gloved hand holding a beaker in a lab setting

Your Data Tells a Story. Let Us Help You Share It.

Every regulatory submission, every investor conversation, every stakeholder meeting depends on how clearly your science is communicated. We bring the technical background to understand your work and the communications expertise to present it to the audiences that need to act on it.

Medical and Scientific Writing for Biotech and Pharma

Regulatory submissions, clinical study reports, medical writing, and scientific communications for early-stage biotech and established pharma companies. Every document is written with a clear understanding of what FDA reviewers expect, what scientific audiences require, and what investors need to hear.

Services include:

IND, NDA, and BLA writing · CMC sections · Clinical study reports · Investigator brochures · Scientific platform development · Investor materials

Strategic Communications for Biotech Companies and Ecosystem Partners

Stakeholder engagement, investor communications, scientific platform development, and ecosystem strategy for biotech companies and the organizations supporting their growth. With particular focus on the emerging biotech market in Northwest Arkansas.

Services include:

Stakeholder engagement programs · Market positioning · Investor communications · Community engagement strategy · Scientific narrative development

Where Scientific Fluency Meets Strategic Clarity

We specialize in bridging commercial goals and scientific integrity.

Most communications agencies bring strategic capability. Most scientific writers bring technical accuracy. Our agency was built to provide both at once.

Technical Depth

Our background in pharmaceutical technical writing and regulatory affairs means the documents we produce reflect an understanding of what FDA reviewers flag, what clinical evidence actually says, and what makes a mechanism-of-action narrative credible to a scientific audience.

Strategic Breadth

From IND applications to community stakeholder strategy, our work spans the full range of audiences that biotech development touches. The regulatory writer and the ecosystem strategist are not separate functions here.

Direct Accountability

As a founder-led consultancy, we maintain direct involvement in every engagement. The expertise you evaluate at the outset is the expertise on the work.

Our team carries genuine pharmaceutical and regulatory writing backgrounds, shaping how we approach every engagement: with enough scientific depth to understand what you're communicating and enough strategic judgment to know how each audience needs to receive it.

From the Insights Hub

Insights feed coming soon.

Ready to Start a Conversation?

Whether you need a regulatory writer, a strategic communications partner, or are still figuring out which one applies, we can help.